98294-08-7

Basic information

• Product Name: 3-hydroxy-3-(trifluoromethyl)indolin-2-one
• Synonyms: 3-hydroxy-3-(trifluoromethyl)indolin-2-one;3-hydroxy-3-(trifluoroMethyl)-2,3-dihydro-1H-indol-2-one;1,3-dihydro-3-hydroxy-3-(trifluoromethyl)-2H-Indol-2-one
• CAS NO: 98294-08-7
• Molecular Formula: C9H6F3NO2
• Molecular Weight: 217.145
• Mol File: 98294-08-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-hydroxy-3-(trifluoromethyl)indolin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-hydroxy-3-(trifluoromethyl)indolin-2-one(98294-08-7)
• EPA Substance Registry System: 3-hydroxy-3-(trifluoromethyl)indolin-2-one(98294-08-7)

Safety Data

• Hazardous Substances Data: 98294-08-7(Hazardous Substances Data)

Upstream product

• 578-66-5 8-amino quinoline 
• 13089-11-7 methyl 3,3,3-trifluoropyruvate 
• 13081-18-0 ethyl-3,3,3-trifluoropyruvate 
• 62-53-3 aniline 
• 91-56-5 indole-2,3-dione 
• 81290-20-2 (trifluoromethyl)trimethylsilane 

Downstream Products

• 1446687-32-6 3-hydroxy-3-(trifluoromethyl)indolin-2-one 
• 1446687-33-7 3-hydroxy-3-(trifluoromethyl)indolin-2-one 

Relevant articles and documents

A NEW REACTION OF METHYL TRIFLUOROPYRUVATE WITH ANILINE

-

SUBSTITUTED 1-BENZYLINDOLIN-2-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE M1 RECEPTORS

In one aspect, the invention relates to substituted 1-benzylindolin-2-one analog compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M

SUBSTITUTED 1-BENZYLINDOLIN-2-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE M1 RECEPTORS

In one aspect, the invention relates to substituted l-benzylindolin-2-one analog compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor Mi (mAChR Mi); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.